塞力医疗: 董事、高级管理人员所持公司股份及其变动管理规则（2025年8月）

Core Points - The document outlines the management rules for the shares held by directors and senior management of Celis Medical Technology Group Co., Ltd, emphasizing compliance with relevant laws and regulations [1][2] - The rules apply to shares registered in the names of directors and senior management, including those held in others' accounts and through margin trading [2][4] - Specific restrictions are placed on share transfers under certain conditions, such as resignation, legal investigations, and company violations [4][5] Share Management - Directors and senior management are prohibited from transferring shares under specific circumstances, including within six months of resignation or during ongoing investigations [4] - A maximum of 25% of their total shares can be transferred annually, with exceptions for certain legal situations [5][6] - If a director or senior management holds fewer than 1,000 shares, they may transfer all shares at once without restriction [6] Information Disclosure - The company secretary is responsible for managing the identity and shareholding data of directors and senior management, ensuring timely reporting of any changes [11][12] - Directors and senior management must notify the board secretary of their trading plans before buying or selling shares [12][13] - Any changes in shareholding must be disclosed within two trading days, including details such as the number of shares before and after the change [11][16] Additional Provisions - The rules will be implemented upon approval by the board and will be subject to relevant laws and regulations [13][18] - The board is responsible for interpreting these rules [13][19]